FIELD: biotechnology.
SUBSTANCE: described is a method of producing an aggregate for use in the manufacture of a soft chewable veterinary dosage form, where the aggregate contains one or more physiologically active macrocyclic lactones (f1), a binder (f2) and a core substance (f3); where the method includes steps of melting binder (f2) and physiologically active macrocyclic lactone (f1) with a core substance (f3) to obtain aggregate (f).
EFFECT: invention extends the range of means for producing aggregates for use in making a soft chewable veterinary dosage form.
5 cl, 16 tbl, 10 ex
Title | Year | Author | Number |
---|---|---|---|
PARASITICIDAL ORAL VETERINARY COMPOSITIONS INCLUDING SYSTEMATICALLY ACTING ACTIVE AGENTS, METHODS AND APPLICATION OF THESE COMPOSITIONS AND METHODS | 2013 |
|
RU2763496C2 |
INJECTABLE PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | 2021 |
|
RU2816232C1 |
PARASITICIDAL ORAL VETERINARY COMPOSITIONS COMPRISING SYSTEMICALLY ACTIVE AGENTS, METHODS AND USE OF THESE COMPOSITIONS AND METHODS | 2013 |
|
RU2660346C1 |
ATTRACTIVE ELASTIC CHEWING VETERINARY COMPOSITION | 2004 |
|
RU2356534C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOOXAZOLINE COMPOUNDS | 2013 |
|
RU2772279C2 |
SOLID PHARMACEUTICAL COMPOSITIONS FOR ORAL ADMINISTRATION BASED ON ISOXAZOLINE COMPOUNDS | 2013 |
|
RU2646483C2 |
SOFT CHEWING PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2632965C2 |
SOFT CHEWABLE PHARMACEUTICAL PRODUCTS | 2013 |
|
RU2765231C2 |
TOPICAL LOCALIZED ISOXAZOLINE FORMULATION COMPRISING GLYCOFUROL | 2011 |
|
RU2602189C2 |
PARASITICIDAL COMPOSITIONS CONTAINING SEVERAL ACTIVE AGENTS, METHODS FOR THEIR USE | 2011 |
|
RU2574887C2 |
Authors
Dates
2024-08-13—Published
2020-07-21—Filed